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Abstract	
Introduction: Malignant disease during childhood is rare, age standardized incidence 
in Europe is 140 in 1 million children. In recent decades survival from childhood 
cancer has increased to over 80%, unfortunately with risk for long term 
complications. Sweden has 11000 individuals that have or have had cancer during 
childhood, of whom 6000-7000 are adults today. The number of complications 
increases with time after diagnosis up to a complication rate of 88% in survivors 20 
years after treatment.  
 
Aim: To summarize general distress, self-reported concerns and complications, and 
possible correlations between them, in a cohort of survivors of childhood cancer from 
the long-term follow-up clinic in Gothenburg.  
 
Method: A retrospective descriptive study of individuals visiting a Long-term follow-
up clinic. All participants were over 18 years, had survived childhood cancer with >5 
years since last treatment. One hundred and six individuals (50 women and 56 men) 
fulfilled the criteria for inclusion and gave permission to use the data. Data was 
collected from medical journals and a questionnaire. Distress was measured using the 
Distress Thermometer.  
 
Results: Complication was found in 86 individuals (81%). Mean number of 
complications was 2.29. Radiotherapy was associated to higher risk of complications 
(p=0.001). New complications were diagnosed in 30% of participants. Mean score of 
general distress was 2.52.There was a correlation between high amount of 
complications and higher score of general distress (p=0.01). Women scored 
significantly higher than men, 3.2 and 1.8 respectively (p=0.005). Women were more 
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likely to have moderate to severe distress (≥4) (p=0.02).  
 
Conclusion: Many childhood cancer survivors develop complications. New 
complications were found in 30% of participants and higher levels of distress were 
found in women and individuals with previously known complications. The results 
indicate that specialized follow-up clinics are helpful for maintaining a good health 
among childhood cancer survivors. 	
Key words: Childhood cancer survivors, Complications, Distress  
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Introduction	
Survival	rate	now	and	then	
The prognosis of childhood cancer has improved and nowadays more than 80% of 
individuals diagnosed with childhood cancer survive. The ACCIS project (The 
Automated Childhood Cancer Information System) is a part of the International 
Agency for Research on Cancer, a branch of the World Health Organization. 
Steliarova-Foucher et al showed a significant improvement in survival from only 44% 
in the 1970's to 73% in the 1990's within the ACCIS project(1). The reduction was 
due to the introduction of modern therapy with combinations of chemotherapy, 
radiation, surgery and supportive care. In 2009 Gatta et al showed that 5-year survival 
for children and adolescents had increased to 81% and 87% respectively (2). They 
also showed a significant reduction of relative risk of death by 8% in children, and by 
13% in adolescents. Over the last decades a total increase in childhood cancer 
incidence can be seen, with an average annual percentage change of 1.1 % (1, 3). 
However this increased incidence has not been seen in Sweden (4). There is a 
discussion if the increase could be due to changed diagnostic procedures or 
registration artefacts (3, 5). Age standardized incidence is now 140 cases in 1 million 
children in Europe (1, 3) which gives a total number of 300 000-500 000 childhood 
cancer survivors. 	
Late	effects	and	complications	
For children who survive, the treatment often leaves permanent marks. In this report 
the word complications will be used, but there are several commonly used terms. 
There is no absolute definition for late complications. Anderson once described it as  
“Any chronic or late occurring physical or psychosocial outcome persisting or 
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developing well after diagnosis of the tumour” (6). In 2006 Oeffinger et al showed 
within the Childhood Cancer Survivor Study (CCSS) that 62% of long-term survivors 
displayed at least one complication, and an increase in the number of late 
complications with time (7). Geenen et al found complications in 75% in a similar 
study in the Netherlands, 2007 (8). In 2015 Phillips et al showed an increase of 
complications from 66% in ages 5-19, up to 88% for survivors between 40-49 years 
old.(9) Generally, morbidity seems to increase with age. The number of survivors 
with severe or life-threatening complications 17 years after diagnose is estimated 
from 27.5% to 40 %.(7, 8) Many survivors also suffer from multiple complications. In 
the Netherlands, Geenen et al showed that 24.6% had five or more adverse events (8), 
Oeffinger et al showed within the CCSS that 23.8% had three or more 
complications(7).  
Late	mortality	
In a Nordic study Möller et al shows a late mortality number of 12,3% during 
extended follow-up of long-term survivors (10). Standardized mortality rate, (SMR) 
for survivors range from 8.3 to 10.8, mostly due to excess mortality from primary 
cancer (11, 12). Möller et al found in 2001 that SMR for second cancer was 4.9, and 
3.1 non-cancer death (11). In 2010 Tukenova et al found SMR to be five times higher 
for cardiovascular diseases for survivors of childhood cancer than the general 
population (12). To reduce cancer-related morbidity and to increase quality of life, 
risk-based health care is one of the corner stones, but both health care providers and 
patients lack knowledge about risks and prevention methods (13). In a study from the 
CCSS, North America, only 31.5% received survivor-focused medical care, 17.8% 
reported discussing risk reduction or screening tests (14). Complications do not only 
impact health, but also factors as education, income and employment. Studies show 
that CNS cancer survivors have less education, lower income and lower employment 
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rate. Non-CNS cancer seemed to be able to reach the same achievements as the 
population in general (15). 	
Self-experienced	health	and	quality	of	life	
Self-experienced health is more complicated to measure in an objective manner. In a 
study by Sundberg et al 68% reported negative consequences, but 53% also reported 
positive consequences, describing a more positive view on life and of self (16). In a 
questionnaire regarding Health Related Quality of Life survivors scored lower than 
the corresponding general population, with women reporting a significantly greater 
burden of morbidity than men (17). Female sex, low household income and low 
educational attainment are factors associated with greater risk of adverse health status 
(7, 16, 18). Literature reviews indicates though that psychological adaptive style is 
more important than actual health status regarding psychosocial outcomes (19). A 
Swedish study of ALL-survivors (Acute Lymphatic Leukaemia) 20 years past 
treatment including CNS-radiation, showed lower neuropsychological function but 
still rated their quality of life as normal (20). General distress is a simple tool used for 
screening after depression, anxiety and psychological effects. Holland et al define 
distress in cancer as following in “Distress Management” in 2010: 
" Distress is a multifactorial unpleasant emotional experience of a psychological 
(cognitive, behavioural, emotional), social, and/or spiritual nature that may interfere 
with the ability to cope effectively with cancer, its physical symptoms and its 
treatment.  Distress extends along a continuum, ranging from common normal 
feelings of vulnerability, sadness, and fears to problems that can become disabling, 
such as depression, anxiety, panic, social isolation, and existential and spiritual 
crisis." (21) 
The Distress Thermometer has become one of the standard instruments for measuring 
distress among cancer patients and survivors from cancer. It is not yet fully validated 
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for use on young childhood cancer survivors, but is recommended as a complement to 
the multidisciplinary care. (22) See Apendix 2 to see the Distress Thermometer. 
Sweden	
Approximately 300 children are diagnosed with cancer in Sweden each year. The 5-
year survival rates in the Nordic countries vary from 75% up to 90%. In an 
international comparison this is a very good result seen to represent the gold standard 
in cancer treatment (23). Despite the improved prognosis, childhood cancer is still the 
most common reason for death among children between 1 and 14 years of age.  
At the moment approximately 11000 individuals in Sweden have or have had cancer 
during childhood, of who 6000-7000 are adult childhood cancer survivors (4, 24). 
Swedish guidelines for follow-up were formed in 2007 by SALUB, Svenska 
Arbetsgruppen för Långtidsuppföljning efter Barncancer (24). In November 2012, a 
long-term follow-up clinic was formed at Sahlgrenska University Hospital. So far, 
approximately 170 patients have visited the clinic. The future plan is to offer all 
childhood cancer survivors in the region of West Sweden a structured summarize of 
their cancer treatment at 18 years, and then a follow-up visit by the age of 24-25. 
Since a structured follow-up clinic has not been available in this region before, 
patients treated in 1985 and later were the first to be invited. Prioritized were 
diagnoses where high rates of complications were expected, such as sarcoma, 
Hodgkin's lymphoma, and leukaemia. In addition, a few patients were referred from 
other clinics or contacted the clinic themselves. Before/during the visit all patients 
have been asked to fill out a questionnaire regarding cancer related distress, areas of 
concern and questions revealing their knowledge about risks and complications for 
their own diagnosis. This questionnaire was used in a clinical setting to identify areas 
of concern for the individual patient. 
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Aim	
To summarize general distress, self-reported concerns and complications, and 
possible correlations between them, in a cohort of survivors of childhood cancer, who 
visited a long-term follow-up clinic in Gothenburg. By assessing distress, areas of 
concern and complications among the survivors, we hope to get a better 
understanding of the needs of this group, but also define areas for improvement in the 
future childhood cancer survivor care and point directions for screening programs and 
future studies. Since this is the first structured follow-up in this region it gives an 
opportunity to survey problematic areas in a way that has not been done before.  
Material	and	methods	
The	cohort	was	chosen	from	the	late-effect	follow-up	clinic,	Sahlgrenska	University	Hospital.	A total of 149 individuals had a first doctor´s appointment at the 
Follow-up clinic between November 2012 and April 2015, of them 129 fulfilled the 
inclusion criteria below. Twenty-three of them either rejected (n=8) or did not answer 
the request (n=15). Overall 106 individuals remained in the study, 50 women and 56 
men. Materials were collected from medical journals and the questionnaire filled out 
in connection with the appointment, see below.  
Inclusion criteria:  
• Childhood cancer diagnosis before the age of 18 
• Attained at least one doctor´s appointment at the follow-up clinic. 
• Age >18 for the time of the visit. 
• >5 years since last treatment. 
• No current relapse. 
• Completed the questionnaire before the visit at the follow-up clinic 
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Questionnaire	and	study	protocol	
From the medical records we collected data about diagnosis, treatment, gender, year 
of birth/diagnosis and time since diagnosis/last treatment. Furthermore, we gathered 
anthropometric data, demographic data, complications sub grouped by organ systems 
and secondary malignancies. For each complication we documented whether the 
complication was previously known or newly discovered, and if any further 
intervention was made. For all variables see the Study protocol in Appendix 1. 
The questionnaire Psykosocial screening för unga vuxna 
som haft cancer före 18 års ålder (Appendix 2) was 
created with an Australian questionnaire (22) as a model. 
The original consists of the distress thermometer, and the 
following multiple-choice questionnaire. For this study 
the questionnaire was translated and validated according 
to the forward- and back-translation procedure. 
According to international recommendations a cut-off 
score for Moderate to Severe Distress was set at a score 
of >4. The recommendation has been questioned, 
but is still considered to be valid for research 
purpose, according to a study comparing the 
Distress Thermometer with the Hospital Anxiety and Depression Scale. (25) A pilot 
version of the questionnaire was first tested on 63 patients. Since it was well accepted, 
and no greater changes were made these individuals were also invited to the study. 
The questionnaire consists of the Distress Thermometer and a section with different 
statements, where the individuals were asked to mark areas of concerns for the last 
month. The questionnaires were first used in a clinical setting, and not primarily for 
Figure	1:1.	The	Distress	Thermometer.	
The	patients	were	asked	to	evaluate	
their	level	of	distress	related	to	the	
previous	cancer	disease	and/or	
treatment.	
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research. Therefore, requests for the permission to use the collected material were 
retrospectively sent out to the patients.  The results from the questionnaires were 
subsequently registered and coded. 
Ethics	
Since the primary purpose of the questionnaires was purely clinical and  private areas 
connected with personal issues and concerns of childhood cancer survivors in a 
relatively small population was investigated, the handling of the material has to be 
done with cautiousness. Therefore an application for an ethic approval was prepared. 
The study was approved by the Regional Ethical Review Board Gothenburg Sweden 
(Dnr: 161-15) March 23rd 2015. 
Statistical	methods	
Statistical analyses were undertaken using the Statistical Package for the Social 
Sciences III version 22.0 (SPSS Inc., Chicago, Illinois, USA). Mean values, standard 
deviations and range were used to describe the distributions in the group.  
Comparisons of all measurements were made with independent samples t-test and 
Pearson´s chi-square test. Simple and multiple linear regression analysis determined 
all correlations. Multiple linear regression was performed with gender, age at follow-
up, age at diagnose, complications before visit and radiation as independent variables, 
and general distress as dependent variable. Results were corrected for multiple 
comparisons by Bonferroni´s method. The level of significance was set at p <0.05. 
Results	
In total 106 individuals participated, 56 men and 50 women. Mean age for visiting the 
Follow-up clinic was 28.1 years (SD 5.9, range 19-42) and mean time since last 
treatment was 17.9 years (SD 5.9, range 5-33). The mean age at diagnose was 8.9 
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years (SD 5.3, range 0.3-18), and mean time since diagnose was 19.5 years (SD 5.8, 
range 7-36). After finished treatment 19 individuals had experienced a relapse during 
childhood, in those cases also the second treatment were registered. A total of 7 
patients had been diagnosed with secondary malignancies. The treatment for 
secondary malignancies were not registered or analysed in our study. The secondary 
malignancies did not require any treatment other than surgery. 
Demographic	data,	educational	level	and	psychosocial	support.	
In total 43.4% (n=46) had either current or finished University studies and 50.9% 
(n=54) had either current or finished Swedish high school education as their highest 
level of education. For 1.9% (n=2) elementary school was the highest achieved 
education. Educational information was missing in 4 individuals. By the time of the 
visit 63.2% (n=67) had an employment, 20.8% (n=22) survivors were studying, 8.5% 
(n=9) were on a longer period of sick leave and 6.6% (n=7) were unemployed. The 
percentage of individuals living alone or with parents was 46.2% (n=49), whereas 
51.9% (n=55) were living with partner and 22.6% (n=24) had biological children. 
Psychosocial support, including assistance for work/school/everyday life as well as 
counselling, was used by 21.7% (n=23) before the visit, and initiated for an additional 
9.4% (n=10) after the visit. Smoking was reported by 12.3% (n=13).  
 
Height and weight was measured in 98 (52 men, 48 women) of the participants. The 
mean body mass index of the men in the study was 25.8 (SD 6.2, range 18.0-49.8) and 
23.9 (SD 5.8, range 15.6-45.0) for the women. Forty-two percent (n=22) of the men 
and twenty-one percent (n=10) of the women were defined as overweight (BMI ≥ 
25). Twenty-five percent (n=13) of the men and eight percent (n=4) of the women 
were defined as obese (BMI ≥30). 
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Diagnoses	
Totally 16 different diagnoses was included, (see 
Table 1:1). The three most common diagnoses were 
ALL, Mb Hodgkin and Sarcoma. Diagnoses were 
firther divided into six diagnostic groups; Leukaemia 
(AML, ALL), Lymphoma, (Mb Hodgkin, Non-
Hodgkin), Sarcoma (Rhabdomyosarcoma, Ewing's 
sarcoma, Osteogenous sarcoma, peripheral PNET), 
Wilm's tumour, Other (Angiofibroma, Retinoblastoma, 
Malignant melanoma, Germ cell tumour, 
Neuroblastoma, Carcinoma), Tumour Cerebri (PNET, 
Germ cell tumour, Ependymoma) (see Fig 1:1).	
	
 n % 
 ALL 30 28,3 
Mb Hodgkin 29 27,4 
Sarcoma 14 13,2 
Wilm's tumour 9 8,5 
Non-Hodgkin  7 6,6 
Neuroblastoma 4 3,8 
Rhabdomyosarcoma 3 2,8 
PNET 2 1,9 
TC 1 ,9 
Retinoblastoma 1 ,9 
Carcinoma 1 ,9 
Angiofibroma 1 ,9 
Malignant Melanoma 1 ,9 
Germ cells tumour 1 ,9 
AML 1 ,9 
Ependymoma 1 ,9 
Table	1:1.		
Many	specific	diagnoses	were	
included	in	the	study.	Below	the	
number	and	percentage	of	each	
diagnose	included	are	presented.	
Figure	1:2.	To	enable	more	statistically	accurate	analyses	the	diagnoses	were	divided	
into	6	major	groups,	presented	above	with	frequencies	distributed	between	genders.	
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Treatment	
There were four major treatment modalities (see Fig 1:2), and 8 combinations of 
them. Almost all patients 98.1%, received chemotherapy. The second most common 
treatment modality was radiotherapy (64.2%). Surgery had been performed in 42.4% 
of the patients and 8.5% (n=9) had been treated with stem cell transplantation (SCT), 
2 of them autologous and 7 allogeneic. The most common combination was 
chemotherapy and radiotherapy. Most individuals were given combination therapies, 
17 (16%) individuals received chemotherapy as only therapy.  
 
General	distress	
Mean general distress was 2.52 (SD 2.38, range 0-9.5) (Fig 1:3). Women scored 
significantly higher than men, ((3.2 (SD 2.4) and 1.8 (SD 2.1), respectively) 
Figure	1:3.	The	patients	could	receive	four	different	modalities	of	treatment,	
Chemotherapy,	Radiation,	Surgery	and	Bone	Marrow	Transplant.	Most	patients	
received	a	combination	of	different	therapies.	The	percentage	of	the	amount	of	
patients	receiving	each	combination	is	shown	above. 
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(p<. 0.005). Moderate to severe distress, (score 4 or more) were found in 24% (n=23). 
Women were more likely to have moderate to severe distress, (17 women, 6 men) 
(p=0.02). The number of complications known before the visit correlated to a higher 
score of general distress (p=0.01). In a multiple regression analysis, higher general 
distress was significantly related to female sex (B=1.26, p=0.03), and to higher 
amount of complications known before the visit (B=0.37, p=0.02) but not to age at 
visit, age at diagnosis or radiotherapy. There was no difference in general distress 
between the diagnostic groups. Eleven individuals did not mark anything on the DT 
and were excluded from the analysis.  	
	
	
Self-reported	areas	of	concern		
The survivors were asked to mark areas of concern for the last month, se Appendix 2. 
The mean total reported areas of concerns were 11.2 (SD 8.9, range 0-43). The 
percentage of participants reporting different amounts of concerns is shown in Fig 
Figure	1:4.	The	patients	were	asked	to	evaluate	the	distress	level	for	the	last	week.	A	
score	above	4	is	considered	as	moderate	to	severe	distress.	The	bars	represent	the	
number	of	patients	marking	each	distress	level	on	the	scale.	
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2:1.	The most commonly marked statement, 44.3% was "Not knowing fertility 
status". The second most common concern with 35.5% was "Worry about having 
long-term effects of treatment". Two of the Emotional statements "Sadness" and 
"Anxiety or fear" got 34% each. Another common area of concern was Concentration, 
where 34% and 28.3% respectively marked the statements "Trouble remembering 
things" and "Short attention span or concentration" respectively. A total of 33% 
respectively 31.1% marked the Physical statements "Problems with sleeping" and 
"Pain" respectively and 30.2% responded positive to the statement of "Feeling 
responsible to have a meaningful life". The remaining statements were marked by less 
than 30% of the patients. In one of the later editions of the questionnaire the statement 
"Feeling stronger as a person" was added. Among the 16 individuals that got the new 
edition 50% percent of them responded positively. For the 20 most common areas of 
concern see Figure 2:2. 
Complications	
Of individuals visiting the clinic, 86 survivors (81%), (44 
women, 43 men) out of 106 were found to have at least 
one complication. Thirty per cent of the survivors were 
diagnosed with new complications as a result from the visit 
at the clinic (19 women, 13 men). The mean number of 
complications after the visit was 2.3 per patient (SD 2.2, 
range 0-12). Three or more complications were found in 
38.7% (n=41) of survivors, and five or more were found in 
10.4% (n=11). For frequencies of total number of 
complications see table 1:2. Individuals treated with 
radiotherapy had significantly higher risk for having at 
 n % 
 None 20 18,9 
1 26 24,5 
2 19 17,9 
3 18 17,0 
4 12 11,3 
5 5 4,7 
6 1 ,9 
7 2 1,9 
8 1 ,9 
12 2 1,9 
Total 106 100,0 
Table	1:2.		
The	total	number	of	
complications	was	summarized	
for	each	patient.	Below	the	
distribution	of	complications	
within	the	group	is	presented	in	
absolute	numbers	and	
percentages. 
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least one complication compared with those not treated with radiotherapy (p=0.001). 
Radiotherapy was also correlated to endocrine problems (p=0.001). No correlation 
was found between radiation and any other specific complication. 
 
Screening,	investigations	and	newly	discovered	complications	
Further endocrine investigation was initiated for 19% (n=20) individuals and 6% 
(n=6) were discovered to have endocrine disturbances demanding substitution 
therapy. Among the women 26% (n=13) were referred for breast cancer screening, 
but no suspect cases have yet been found. Screening programs for heart problems 
(mainly echocardiogram every 5th year) were arranged for 63.2 % (n=67). Regular 
palpation of thyroid gland and levels of thyroid hormones in blood was initiated for 
36.8% (n=39). Referral to a general practitioner or dermatologist for check-up of skin 
lesions was made for 53.8% (n=57). For frequencies of each complication see Figure 
2:3. 
 
Infertility included both complete infertility and partially reduced fertility where 
medical assistance was needed to achieve pregnancy. All survivors with known 
fertility-affecting treatment were offered further investigation and 20 individuals were 
referred to the Reproduction Clinic. Nine of them have yet been found to be infertile. 
Twenty-one persons had been diagnosed with infertility before the visit.  
Hypertension was found in 6% (n=6) of individuals. Musculoskeletal and/or 
connective tissue affecting complications were found in 6% (n=6). Complications in 
mouth and throat were found in 3% (n=3). Neurologic disturbances and hearing 
impairment were discovered in 2% (n=2) each and pulmonary diseases, urinary tract- 
and gastrointestinal complications were found in 1% (n=1) each.  
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Discussion		
In this study we found a high rate of physical complications. General distress was 
higher in those patients that already had at least one complication before the visit and 
especially in women. We found high numbers of concerns regarding possible 
complications as infertility, but many also marked statements as "Sadness",  "Anxiety 
or fear" and "Trouble remembering things". Because of the short amount of time, 
there was no possibility to compare these childhood cancer survivors to a control 
group without a previous history of cancer. The question is if these levels of distress 
and areas of concern would differ so much from a cancer-free population of the same 
age. The transition from adolescence to adulthood is a time of change and challenges 
for most human beings. A time of big decisions and new responsibilities, which tests 
the ability to cope with stress and new situations.  
General	distress	
The Distress Thermometer, DT is becoming more and more recognized within in the 
cancer care internationally, but there is still an on-going process of validation when 
screening adult survivors after childhood cancer. When using the DT, a score over 4 
is generally considered as moderate to severe distress. (22) In this study the mean 
level of distress was significantly higher for women than men and they were also 
more likely to score 4 or more. There was also a significant correlation between 
amount of complications before the visit and general distress, but no difference in 
complications between men and women. It is questionable if the females de facto did 
experience a higher level of distress, or if it is an expression of different ways of 
valuing and expressing distress. Earlier studies show higher level of distress in female 
haematological patients than in men (26), but also higher frequencies of depression in 
female cancer survivors than in women not previously diagnosed with cancer (27). A 
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study on outpatients affected with anxiety disorders (without a previous history of 
cancer) showed a higher prevalence of anxiety disorders in women, but also showed 
that women scored higher on self-rated scales, but not on observer-rated scales (28). 
A study investigating distress in oncology patients, comparing the Hospital Anxiety 
and Depression Scale (HADS) and a classic thorough clinical assessment showed less 
agreement between the methods among males than females (29), and a similar 
situation cannot be ruled out also regarding the Distress Thermometer. Further 
validation should pay attention to possible difference in approach between genders.   
Self-reported	concerns	
The two most common concerns "Not knowing fertility status" and "Worry about 
having long-term effects of treatment" covers areas that can be dealt with through 
investigations and screening programs. Earlier studies show that the risk of infertility 
varies with therapy modality, sex, tumour site and age at diagnose (30, 31). To 
educate the survivors about what risks they actually do have due to their disease and 
treatment reduces "unnecessary" anxiety. A very high percentage (44.3%) worried 
about fertility, but of those referred for investigations only 9 were found to be 
infertile. Several individuals expressed that the follow-up brought up worries about 
what complications they might be at risk for, but also that it was better to know than 
not to. A substantial part of the anxiety could be reduced already at the clinic since the 
given treatment did not increase the risk for that specific subject. A few asked for a 
new visit some months after the first because of new thoughts and worries. In the 
future it would be interesting to measure the general distress also after the follow-up.  
Questionnaire	
In this study we focused mainly on problems and negative effects. When filling out 
the questionnaires several patients pointed at the lack of "positive effects". Sixteen 
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individuals got a later edition where the statement "Feeling stronger as a person" was 
added, among them 50% percent responded positively. Future studies could benefit 
from looking for factors connected with better self-reported health, as a way of 
helping survivors to a better life. To reach out to parents/relatives that was present 
during the years of disease and treatment could also give a wider perspective as many 
of the survivors were diagnosed as young children. A study within the CCSS focused 
on Positive Perceived Impact (PPI), which showed that women, non-White and 
patients exposed for intense therapy, relapse or second malignancy actually endorsed 
greater PPI than others (32). This does not automatically contradict distress, but 
contributes to a sense of meaning to life, which supposedly helps tackling 
complications.  
Complications	
Childhood cancer is a heterogeneous group when it comes to cancer diagnoses and 
with a great variety of treatment modalities. In this cohort there was a wide variation 
of diagnoses, and a relatively high number of individuals treated with radiotherapy. 
Previous studies have pointed out radiation as a risk factor both for physical(33) and 
psychological complications (34). The patient cohort in this study is selected since a 
high number of complications were suspected for the diagnoses of the majority of 
patients who visited the clinic. This might contribute to a higher number of 
complications in our group than expected. We also had a wide time range since 
diagnosis and finished treatment.  
Relatively many complications were discovered at follow-up compared with earlier 
studies(7-9), and presumably additional late effects will be diagnosed since not all 
patients have yet been investigated due to long waiting periods. For the complications 
that were found, the most frequent complications had no overt symptoms, such as 
infertility and hypertension. Endocrine disturbances have unspecific but still very 
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affecting symptoms, such as fatigue, depression and weight gain. Other complications 
(such as musculoskeletal pain) were not completely unknown, but were not until the 
visit at the clinic confirmed to be a complication to their previous cancer and/or 
treatment. This might have prevented the survivors from getting the proper treatment 
and support from school, social services or other instances. Some of the elder 
survivors might have benefitted from discovering some of the complications earlier in 
life, to be able to take that in account when making life-decisions and to get proper 
support with studies and work. For those affected with infertility, preventive actions 
or spontaneous pregnancy may have been possible if discovered in an earlier stage. 
However, the methods for fertility preservation appropriate for this patient group have 
only been available during the most resent years. Since our main focus in this study 
was distress and areas of concern, we did not grade the severity of the complications. 
The number of survivors having three or more complications was slightly higher than 
what Oeffinger showed within the CCSS (7), but the number of individuals with five 
or more was slightly lower than in Geenen's study(8). This might be explained by the 
small number of brain tumour survivors in our study. 
Strengths	and	weaknesses	
The study was performed on a patient cohort who had been invited to the long-term 
follow up clinic in Gothenburg. Since the data was collected from already existing 
material it did not ask for any further effort from the participants, and a high 
percentage (82%) approved to our request. All patients included was examined by the 
same doctor. 
External	loss	and	limitations	
The selection of patients invited to participate in the study was based on patients that 
had already visited the clinic. Some of the patients had contacted the clinic 
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themselves, but a big majority received an invitation from the clinic. Invitations were 
sent to specific diagnose groups based on expected complication rate. Since the 
participants only were picked from patients that actually chose to visit the clinic, we 
also excluded some patients that possibly did not experience any effects from their 
cancer and therefore felt no need for a follow-up. However, some of the most 
cognitive affected individuals could not participate in our study, which excludes one 
group with presumably high levels of distress and complications. An important group 
of patients not sufficiently represented in this study is survivors from brain tumours. 
This is a group known for having the highest rate of complications, but has not yet 
been invited to the follow-up clinic. 
Internal	loss	
Eleven patients did not mark anything at the Distress Thermometer. This might be 
because they did not understand the term, they did not understand that they were 
supposed to mark it, or they did not experience any distress and "marked" that by not 
marking anything. Those answers were excluded from the analyses. Furthermore 2 
individuals marked two numbers, which was registered as the mean value of them. 
They were included in the mean values, but not in the Chi-square tests. Some patients 
had marked alternatives among the self-reported concerns in a way that made it 
uncertain if they meant to mark it. Those statements were excluded from the analysis.  
Conclusion	
Many childhood cancer survivors have developed complications as a result of 
treatment or disease. In this study, new complications were found in 30% of the 
participants and higher levels of distress were found in women and individuals with 
previously known complications. The results indicate that the general health care fails 
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to meet the needs for childhood cancer survivors when it comes to finding new 
complications, establishing screening programs and educating the survivors about 
what risks they might be at stake for. Therefore, increased knowledge and 
organization for this growing patient group in the health-care system is needed.	
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Populärvetenskaplig	sammanfattning	på	svenska	
Unga	vuxna	efter	barncancer-	hälsomässiga	och	psykosociala	konsekvenser	
av	behandling	och	sjukdom	
Bakgrund: Barncancer är en ovanlig sjukdom, cirka 140 av 1 miljon barn drabbas. 
Överlevnaden efter barncancer har ökat de senaste årtiondena. Idag överlever mer än 
80 % en barncancerdiagnos. Detta gör att antalet personer i samhället som haft cancer 
som barn ökar. I Sverige finns ungefär 11 000 personer som har eller har haft 
barncancer, av dessa är 6000-7000 vuxna idag. Tidigare forskning visar att upp till 88 
% av överlevare har komplikationer 20 år efter sjukdom och behandling. I 
undersökningar uttrycker många icke-barncancerspecialister en osäkerhet kring 
eventuella risker och behandling av före detta barncancerpatienter. I november 2012 
startades på Jubileumskliniken Sahlgrenska, en Uppföljningsmottagning för unga 
vuxna. Det är en mottagning för överlevare efter barncancer.  
 
Syfte och metod: Att sammanställa oro/distress, egenupplevda bekymmer och 
komplikationer hos barncanceröverlevare som har besökt Uppföljningsmottagningen 
på Sahlgrenska Universitetssjukhuset. Material hämtades från journaler och enkäter 
som patienterna fick fylla i själva. Enkäten innehöll en Distress Termometer där oro 
skattades från 0-10, och en lista med olika områden för bekymmer.  
 
Resultat: Totalt 106 personer deltog i vår studie, 50 kvinnor och 56 män. Alla hade 
fått en barncancerdiagnos innan 18 års ålder, och minst 5 år hade gått sedan senaste 
behandlingen. Av alla deltagare hade 81 % minst en komplikation. I snitt hade varje 
deltagare drygt två komplikationer. Strålbehandling gav högre risk för komplikationer 
och nya komplikationer hittades hos 30 % av deltagarna. De tre vanligaste 
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komplikationerna var smärta/stelhet/förtvining i muskler och leder, infertilitet 
(svårigheter att få barn) och nedsatt produktion av sköldkörtelhormon, Kvinnor och 
personer med tidigare kända komplikationer skattade en högre generell oro/distress. 
De vanligaste områdena för bekymmer var "Vet ej om jag kan få barn" och "Oro för 
sen-effekter pga. cancerbehandlingen".  
 
Slutsats: Många överlevare har komplikationer och oro kopplat till sin tidigare 
barncancer. För de barn som överlever en cancerdiagnos återstår många år av livet. 
Det är viktigt att dessa år ges så god kvalitet som möjligt. Många unga överlevare har 
i media belyst brister i uppföljningen inom vuxenvården. För att möta deras behov 
behövs specialiserade center för uppföljning, med kunskap om risker och 
komplikationer för olika behandlingar och sjukdomar. Detta möjliggör 
riskförebyggande insatser och screeningprogram för till exempel hjärtfel och nya 
cancersjukdomar.  	 	
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Figures	
Figure	2:1.	The	patients	were	given	a	list	of	statements	and	were	asked	to	
mark	areas	of	concern	for	the	past	month.	The	total	number	of	concerns	
marked	by	each	individual	was	summarized	and	presented	above.	 	
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Figure	2:2.	The	patients	were	given	a	list	of	81	statements,	and	were	asked	
to	mark	areas	of	concern	for	the	past	month.	Above	is	shown	the	20	most	
commonly	marked	areas	of	concern,	presented	in	decreasing	order.	 		 	
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Figure	2:3.Complications	of	19	different	categories	were	summarized	for	
each	patient.	Frequencies	for	each	category	are	presented	above	in	
decreasing	order.	 	
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Appendices	
Study	Protocol		
Number 
Year of birth  
Gender  1  Woman                   2  Man 
Length Weight BMI   
Year of diagnosis 
Age of diagnosis 
Years since last oncologic treatment  
Year since diagnosis  
Kind of tumour  
 Mb Hodgkin   1 
                    Sarcoma   2                                    TC            6             neuroblastoma 10 
                    Wilm's     3                     retinoblastoma       7 
                    PNET       4                        carcinoma             8               
                    ALL          5                     angiofibroma           9 
Relapse 
Treatment 
Surgery 
Chemotherapy 
Kind of chemotherapy  
 Anthracyclines   1 
 Alkylating agents       2 
 Platinum compounds  3 
 Vinca Alkaloids   4 
 Other   5 
Localization for radiation   None 0          1  Brain   2  Head and neck  3  Thorax   4  
Abdomen   
5  Extremities   
Dosage 
Civil status       Missing      0 
Living alone/with parents   1 
Married/living as married     2 
Partner, but not living together   3 
Children      no   1 yes 1 
Highest level of education 
Missing   0              Elementary school     1 
College   2               University     3 
Occupation 
Missing  0                  Working   1 
Studying        2                    Sick leave     3       Unemployed      4 
Psychosocial support  
None 0  Already in contact     1 
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Contacted initiated after the visit    2 
 
Late complications 
Hypertension         
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Heart failure 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Other heart disease 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention 
Hypo/hyperthyroidism 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Secondary Malignant Thyroid Disease  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Breast Malignancy  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Breast hypoplasia  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Pulmonary diseases 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Reduced fertility or complete infertility  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Endocrine disturbance  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Kind of disturbance  
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None  0 
Thyroid hormones  1                Other   5 
Sex hormones     2 
Growth hormones    3 
Diabetes               4 
Intervention   Yes    1   No    0 
 
Neurologic disturbances  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Kind of disturbance  
None    0 
Neuropathies    1 
Other   2 
Neurocognitive    3 
Intervention   Yes    1   No    0 
 
Urinary Tracts  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Gastrointestinal complications 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Mouth, Throat and Teeth 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Hearing Impairment 
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
 
Impaired vision  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Musculoskeletal complications 
None    0   Yes- already known complication   1   
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Complication discovered /started investigation during the visit       2 
Kind of complication 
Atrophy   1 
Scoliosis/kyphosis  2 
Other   3 
Intervention   Yes    1   No    0 
 
Skin  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Kind of skin lesion 
None   0 
Malignant lesion   1 
Benign lesion   2 
Other         3 
Intervention   Yes    1   No    0 
 
Spleen/Immunology  
None    0   Yes- already known complication   1   
Complication discovered /started investigation during the visit       2 
Intervention   Yes    1   No    0 
 
Hepatitis C 
 
Other 
 
Secondary malignancies 
 
Complications in total 
 
 
 
 
 
 
 
 
 
 
 
 	 	
!!
Psykosocial*screening*för*unga*vuxna*
som*haft*cancer*före*18*års*ålder*! ! ! !! ! ! ! ! ! !!!!!!!!!!!!!!!!!!!!!!!!!!!!140310!
1. Distress allmänt 
Ringa in den siffra (0-10) som bäst beskriver hur mycket distress (bekymmer/besvär) du upplevt 
den senaste veckan inklusive idag som är kopplat till din tidigare cancerdiagnos/behandling!!!
!!!!!!!
2 Specifika områden för bekymmer/besvär eller anpassningsförmåga? 
Var snäll och kryssa för de områden som har varit ett problem för dig under den senaste 
månaden inklusive idag (behöver inte vara direkt relaterat till din cancerdiagnos): !!
 Fysiskt   Konsekvenser av min cancer-erfarenhet 
     
 Allmänt tillstånd   Avsaknad av trygg framtid 
 Ätande eller aptit   Identitets förändring 
 Förstoppning eller diarré   Förlust av livsmening/mål med livet 
 Sexuella bekymmer   Förlust av ekonomisk självständighet 
 Smärta/värk   Ifrågasättande av tro eller andlighet 
 Anpassning till ny funktionsnivå   Sorg över andra patienters död 
 Mindre ork än före cancer   Skuld över andra patienters död 
 Lägre kapacitet för ”normala” aktiviteter   (”överlevnads skuld”) 
 Oförmögen att träna som jag brukade   Känner ansvar för att leva ett  
 Känner mig svag   ”meningsfullt liv” 
 Sömnproblem    
 Biverkningar av behandlingen    
    
 
 
Uppföljningsmott. Unga Vuxna/Väst 
Namn: 
 
Datum för ifyllande: 
Distress är svåröversatt, men kan 
beskrivas som en obehaglig och ofta 
komplex upplevelse som kan ta sig 
uttryck i fysiska, psykiska, social 
och/eller existentiella symtom. Man kan 
säga att det handlar om upplevda 
bekymmer och besvär. 
Här ska upplevelsen vara kopplad till 
din cancerdiagnos och/eller den 
cancerbehandling du fått. 
Ques%onnaire
!!
     
 Känslomässigt   Familjen 
     
 Nedstämd/ledsen   Upplever att familjen inte förstår 
 Känner mig ensam eller isolerad   Brist på stöd från familjen 
 Oro/ångest eller rädsla   Känner ansvar för att ”skydda” 
 Skuldkänslor   familjen från sanningen 
 Uttråkad   Behov av mer hjälp/stöd än familjen 
 Ilska eller frustration   kan ge 
 Extremt negativa känslor   Oro för vilken påverkan cancern haft 
 Känns som allting kräver en ansträngning   på familjen 
 Känsla av hopplöshet eller hjälplöshet   Oro för familjemedlemmar 
 Känsla av förvirring    
 Livet känns meningslöst   Socialt 
 Självmordstankar    
    Känner mig isolerad från vänner 
 Koncentration   Vill/kan inte göra ”normala saker” 
    med mina vänner 
 Kort uppmärksamhetsfokus eller   Mina vänner förstår mig inte 
 koncentrationsförmåga   Känner mig annorlunda jämfört med 
 Problem att komma ihåg saker   mina vänner 
 Tar längre tid att slutföra saker än tidigare   Vill/kan inte träffa nya människor 
    Oro för flick-/pojkvän/partner 
 Fertilitet/fortplantning   Kris i relationen med partner 
     
 Vet inte om jag kan få barn   Survivorship/överlevnad 
 Känner inte till vilken hjälp som finns att få    
 för att få barn   Vill inte berätta för andra att jag haft 
 Oro för kostnader för fertilitetsbehandling   cancer 
 Oro över att diskutera fertilitet med    Döljer ”äkta” känslor för andra 
 partner/framtida partner   Håller ”skenet uppe” inför kompisar 
 Sorg över barnlöshet   Upplever att jag gått miste om livet 
    pga cancer 
 Livsstil   Svårt att acceptera ändrade om- 
    ständigheter pga cancer 
 Röker cigaretter   Oro för att familj/vänner ska få cancer 
 Dricker alkohol   Oro för att familjen har ”cancergen” 
 Använder droger   Oro för att få barn med ”cancergen” 
 Gör andra saker som riskerar livet   Oro för sen-effekter pga cancer- 
 Har oskyddad sex   behandlingen 
 Har en ohälsosam livsstil   Oro för att cancern ska komma tillbaka 
 Sköter inte bokade möten (bla medicinska)    Orostankar om död och döende 
     
 Arbetsmarknad   Utbildning 
     
 Att få ett jobb   Återgång till utbildning 
 Återgång i arbetet   Komma ikapp med studier 
 Stöd från arbetsgivare   Problem med studiekamrater 
 Diskriminering på arbetet   Problem med lärare/föreläsningar/  
 Problem med arbetskamrater   personal 
 Ändrade karriär strävanden   Behov av speciella åtgärder !!!!
!!
!!!____________________________________________! 1.____________________________________________!!____________________________________________! 2.____________________________________________!!____________________________________________! 3.____________________________________________!!____________________________________________! 4.____________________________________________!!!
Var snäll och markera vilken ytterligare information som du anser skulle vara användbar: !
Din cancerdiagnos! ! Långtidsuppföljning! ! Studievägledning! !
Genomförd behandling! ! Ekonomisk rådgivning ! Arbetsmarknadsrådgivning! !
Psykosocialt stöd! ! Fertilitetsrådgivning! ! Vägar till förbättra hälsa! !
Stöd grupper! ! Ärftlig cancer ! Fritidssysselsättningar! !!!
Här nedan följer ett antal frågor som är mycket värdefulla för vårt fortsatta 
omhändertagande av dig och vår fortsatta verksamhet (använd gärna baksidan vb) !!
Vilken tumörsjukdom har du fått behandling för:______________________________ 
 
Hur gammal var du när du fick din diagnos?_________________________________ 
 
Vad fick du för behandling (sätt kryss för det som är aktuellt): 
 
 Cytostatika  Strålbehandling  Kirurgi(operation)  Transplantation 
 
Vet du idag om du har något problem som du kopplar till din tidigare cancersjukdom 
eller behandling?     
 Ja  Nej 
 
Om ja, vilket/vilka?______________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
 
Vet du idag om du på grund av din tidigare cancersjukdom/behandling har någon ökad 
risk för biverkningar i framtiden?  
 Ja  Nej 
 
Om ja, vilket/vilka?_______________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
Vilka är dina mål för framtiden? Andra saker jag vill ta upp… 
!!
 
 
 
 
Aktuella sjukvårdskontakter:_______________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
Aktuella läkemedel:______________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
Övriga uppgifter av värde:_________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
Jag godkänner att ovanstående information får användas av mitt team på Uppföljningsmottagningen för 
mitt fortsatta omhändertagande. 
 
 
 
 
Med tillåtelse av AYA Oncology Psychosocial Survivorship Screening Tool Youth Cancer Service SA/NT 
(2013) 
Underskrift/patient:! ! ! ! ! Datum:!
